These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8018915)

  • 1. Prothrombin synthesis and degradation in rat hepatoma (H-35) cells: effects of warfarin.
    Zhang P; Suttie JW
    Blood; 1994 Jul; 84(1):169-75. PubMed ID: 8018915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of warfarin on the intracellular processing of vitamin K-dependent proteins.
    Wu W; Bancroft JD; Suttie JW
    Thromb Haemost; 1996 Jul; 76(1):46-52. PubMed ID: 8819250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin K dependent in vitro production of prothrombin.
    Swanson JC; Suttie JW
    Biochemistry; 1982 Nov; 21(23):6011-8. PubMed ID: 6758841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural features of the kringle domain determine the intracellular degradation of under-gamma-carboxylated prothrombin: studies of chimeric rat/human prothrombin.
    Wu W; Bancroft JD; Suttie JW
    Proc Natl Acad Sci U S A; 1997 Dec; 94(25):13654-60. PubMed ID: 9391081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin K-dependent carboxylase activity, prothrombin mRNA, and prothrombin production in two cultured rat hepatoma cell lines.
    Shah DV; Zhang P; Engelke JA; Bach AU; Suttie JW
    Thromb Res; 1993 Jun; 70(5):365-73. PubMed ID: 8378893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of vitamin K1 and warfarin on prothrombin expression in human hepatoblastoma (HepG2) cells.
    Jamison CS; Burkey BF; Degen SJ
    Thromb Haemost; 1992 Jul; 68(1):40-7. PubMed ID: 1325077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Processing and trafficking of clotting factor X in the secretory pathway. Effects of warfarin.
    Stanton C; Wallin R
    Biochem J; 1992 May; 284 ( Pt 1)(Pt 1):25-31. PubMed ID: 1599403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of warfarin on prothrombin synthesis and secretion in human Hep G2 cells.
    Karpatkin S; Finlay TH; Ballesteros AL; Karpatkin M
    Blood; 1987 Sep; 70(3):773-8. PubMed ID: 3040156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The biochemical basis of warfarin therapy.
    Suttie JW
    Adv Exp Med Biol; 1987; 214():3-16. PubMed ID: 3310547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurement of immunoreactive prothrombin precursor and vitamin-K-dependent gamma-carboxylation in human hepatocellular carcinoma tissues: decreased carboxylation of prothrombin precursor as a cause of des-gamma-carboxyprothrombin synthesis.
    Ono M; Ohta H; Ohhira M; Sekiya C; Namiki M
    Tumour Biol; 1990; 11(6):319-26. PubMed ID: 2173855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for competition between vitamin K-dependent clotting factors for intracellular processing by the vitamin K-dependent gamma-carboxylase.
    Stanton C; Ross P; Hutson S; Wallin R
    Thromb Res; 1995 Oct; 80(1):63-73. PubMed ID: 8578539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biosynthesis of prothrombin: intracellular localization of the vitamin K-dependent carboxylase and the sites of gamma-carboxylation.
    Bristol JA; Ratcliffe JV; Roth DA; Jacobs MA; Furie BC; Furie B
    Blood; 1996 Oct; 88(7):2585-93. PubMed ID: 8839851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal prothrombin in the vitamin K-deficient rat.
    Shah DV; Swanson JC; Suttie JW
    Thromb Res; 1984 Aug; 35(4):451-8. PubMed ID: 6484892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early processing of prothrombin and factor X by the vitamin K-dependent carboxylase.
    Wallin R; Martin LF
    J Biol Chem; 1988 Jul; 263(20):9994-10001. PubMed ID: 3290218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-glycosylation contributes to the intracellular stability of prothrombin precursors in the endoplasmic reticulum.
    Wu W; Suttie JW
    Thromb Res; 1999 Oct; 96(2):91-8. PubMed ID: 10574586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of vitamin K status in human subjects administered "minidose" warfarin.
    Bach AU; Anderson SA; Foley AL; Williams EC; Suttie JW
    Am J Clin Nutr; 1996 Dec; 64(6):894-902. PubMed ID: 8942414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levels of vitamin K, immunoreactive prothrombin, des-gamma-carboxy prothrombin and gamma-glutamyl carboxylase activity in hepatocellular carcinoma tissue.
    Yamagata H; Nakanishi T; Furukawa M; Okuda H; Obata H
    J Gastroenterol Hepatol; 1995; 10(1):8-13. PubMed ID: 7620113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism for potentiation of warfarin by phenylbutazone. Inhibition of vitamin K-dependent carboxylation and prothrombin synthesis by phenylbutazone in preparations from rat liver.
    Kelly LJ; Bell RG
    Biochem Pharmacol; 1981 Sep; 30(17):2443-9. PubMed ID: 21043243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal prothrombin in the plasma of rats carrying hepatic tumors.
    Shah DV; Engelke JA; Suttie JW
    Blood; 1987 Mar; 69(3):850-4. PubMed ID: 3814818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secretion, gamma-carboxylation, and endoplasmic reticulum-associated degradation of chimeras with mutually exchanged Gla domain between human protein C and prothrombin.
    Tokunaga F; Takeuchi S; Omura S; Arvan P; Koide T
    Thromb Res; 2000 Sep; 99(5):511-21. PubMed ID: 10973682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.